Cai Lei’s 2026 Open Letter: ALS Progress Amid Personal Struggle
JD.com’s former VP Cai Lei shares his 2026 health update and progress in international ALS research through an eye-written open letter.
News & Insights Across Asia
JD.com’s former VP Cai Lei shares his 2026 health update and progress in international ALS research through an eye-written open letter.
Despite losing his voice, Cai Lei’s AI-driven advocacy has accelerated ALS research in China, yielding 40 clinical pipelines and over 200 treatments. His legacy inspires a new chapter in medical collaboration.
Former internet mogul Cai Lei and partner Duan Rui dedicate their lives to ALS research, overcoming personal health challenges to advance medical innovation.
Chinese entrepreneur Cai Lei continues advancing global ALS research and patient support despite being ineligible for breakthrough drug Rag-17 due to genetic factors.
Former executive Cai Lei battles ALS while leading advocacy efforts in Asia, inspiring hope through research and awareness on Global ALS/MND Day.